Viewing Study NCT00038103


Ignite Creation Date: 2025-12-24 @ 7:42 PM
Ignite Modification Date: 2026-02-05 @ 8:44 PM
Study NCT ID: NCT00038103
Status: COMPLETED
Last Update Posted: 2010-02-25
First Post: 2002-05-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasms View
Keywords: